An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213549
Company: PD PARTNERS

Products on ANDA 213549

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SUCRALFATE	SUCRALFATE	1GM/10ML	SUSPENSION;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 213549

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/17/2024	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 213549

SUCRALFATE

SUSPENSION;ORAL; 1GM/10ML
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CARAFATE	SUCRALFATE	1GM/10ML	SUSPENSION;ORAL	Prescription	Yes	AB	019183	ABBVIE
SUCRALFATE	SUCRALFATE	1GM/10ML	SUSPENSION;ORAL	Prescription	No	AB	216726	ABON PHARMS LLC
SUCRALFATE	SUCRALFATE	1GM/10ML	SUSPENSION;ORAL	Prescription	No	AB	209356	AMNEAL
SUCRALFATE	SUCRALFATE	1GM/10ML	SUSPENSION;ORAL	Prescription	No	AB	212913	MYLAN
SUCRALFATE	SUCRALFATE	1GM/10ML	SUSPENSION;ORAL	Prescription	No	AB	213549	PD PARTNERS
SUCRALFATE	SUCRALFATE	1GM/10ML	SUSPENSION;ORAL	Prescription	No	AB	211884	VISTAPHARM LLC

Top